Plain-English translation of NCT05181696 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking back at medical records and chest X-rays from patients who were hospitalized with severe COVID-19 pneumonia between 2020 and 2021. By studying how lung inflammation appeared on these X-rays and tracking blood tests and vital signs over time, the team hopes to create a better scoring system to predict which patients will recover and which may develop serious complications.
During the pandemic, doctors needed better ways to quickly assess how severe COVID-19 pneumonia was in each patient and predict outcomes. This study aims to develop a clearer, more reliable system for measuring lung damage from COVID-19, which could help doctors make faster treatment decisions in future outbreaks.
This is a retrospective study, which means researchers will review your existing medical records, chest X-rays, and blood test results from your hospital stay — you won't need to do anything new or visit the hospital. Specialists will carefully analyze your X-rays using a standardized scoring system and track how your blood markers and vital signs changed during your treatment.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Croatia
Enrollment target
~200 participants
Started
January 2020
Primary completion
May 2025
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nenad Nešković, PhD
University Hospital Osijek